Clinical Trials Browser

Phase 2 × Has results × E-3810 × Clear all

NCT02202746 2020-06-23

A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer

Phase 2 Terminated

178 enrolled 20 charts

Breast Neoplasms